95% CI, 78-99) of patients treated with G/P for 12 or 16 weeks, respectively
A study of nearly 13,000 people with diabetes and asthma found that metformin cut a patient's odds for asthma attacks by 30%, while adding in a GLP-1 med reduced it by another 40%
Most of retatrutide's effects come from reducing fat mass, likely because it helps people eat less food for longer periods compared to similar medications
Mechanism of malignant hyperthermia (MH) driven by pathogenic RYR1 variants
Nn ung Biocyte Glutathion Liposomal vo lc no
We thank all members of the IRB who participated in the DSMB for this study: Katherine Freeman, MPH, Morri Markowitz, MD, Shlomo Shinnar, MD and Mark Sinnett, PharmD